AmberGen

Amber Gen

Biotechnology, 313 Pleasant St Ste 4, Billerica, Massachusetts, 02472, United States, 11-50 Employees

ambergen.com

  • facebook
  • LinkedIn

phone no Phone Number: 61********

Who is AMBERGEN

AmberGen is a biotechnology company and producer of MiralysTM spatial biology imaging solutions. MiralysTM, also known as MALDI HiPLEX-IHC, is a new breakthrough method for targeted intac...

Read More

map

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from AMBERGEN

AmberGen Org Chart and Mapping

VP-Level
Employees

Rajiv Pande

Microarray Project Manager

Sergey Mamaev

Senior Research Scientist

Richard Del Mastro

Director, Molecular Therapeutics Division

Shawn Carlson

Field Applications Engineer

Leonardo Dettori

Postdoctoral Research Staff Scientist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding AmberGen

Answer: AmberGen's headquarters are located at 313 Pleasant St Ste 4, Billerica, Massachusetts, 02472, United States

Answer: AmberGen's phone number is 61********

Answer: AmberGen's official website is https://ambergen.com

Answer: AmberGen's revenue is $1 Million to $5 Million

Answer: AmberGen's SIC: 2836

Answer: AmberGen's NAICS: 541714

Answer: AmberGen has 11-50 employees

Answer: AmberGen is in Biotechnology

Answer: AmberGen contact info: Phone number: 61******** Website: https://ambergen.com

Answer: AmberGen is a biotechnology company and producer of MiralysTM spatial biology imaging solutions. MiralysTM, also known as MALDI HiPLEX-IHC, is a new breakthrough method for targeted intact protein imaging that has unique multimodal imaging capabilities. First introduced in 2022, it has gained significant traction, including 8 of the top 10 pharma companies, as well as many of the worlds premier research institutions. It is currently being used to study tissues for a wide range of diseases including cancers, Alzheimers and Parkinsons diseases; and even COVID. Benefits include: - Drug/target co-localization on the same sample, same instrument - The ability to produce images that co-register small molecule lipids and metabolites as well as the intact targeted proteins. - The products combination of fast, targeted, protein imaging (scan time as short as 45 min and 1cm2), ultra-high plex (10 to 100+), wide viewing area (up to 25 x 75 mm), and multi-modal capability make it an ideal technology for doing initial scans to identify regions of interest for later deep-dive analysis. - MiralysTM requires no dedicated instrument, and minimal investment to start using. It is used on MALDI Mass Spec Imaging instruments that your institution most likely already owns, such as the industry-leading instruments from our partner, Bruker Corporation.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access